Copyright 2009 Medical News Today Latest Erectile Dysfunction / Premature Ejaculation News From Medical News Today. http://www.medicalnewstoday.com/sections/erectile_dysfunction/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 20 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/171596.php http://www.medicalnewstoday.com/articles/171596.php At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Results of the double-blind treatment phase of this study, which enrolled patients from the U.S. Erectile Dysfunction / Premature Ejaculation Thu, 19 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171452.php http://www.medicalnewstoday.com/articles/171452.php Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED). The multi-center study conducted in Korea was a randomized, double-blind, placebo-controlled study, designed to investigate the efficacy and safety of udenafil in patients with ED. Erectile Dysfunction / Premature Ejaculation Thu, 12 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170628.php http://www.medicalnewstoday.com/articles/170628.php High levels of workplace exposure to Bisphenol-A may increase the risk of reduced sexual function in men, according to a Kaiser Permanente study appearing in the journal Human Reproduction, published by Oxford Journals. [1] The five-year study examined 634 workers in factories in China, comparing workers in BPA manufacturing facilities with a control group of workers in factories where no BPA was present. Erectile Dysfunction / Premature Ejaculation Tue, 10 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/170430.php http://www.medicalnewstoday.com/articles/170430.php In an advance that could one day enable surgeons to reconstruct and restore function to damaged or diseased penile tissue in humans, researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine have used tissue engineering techniques to completely replace penile erectile tissue in animals. In the online early edition (Nov. Men's health Mon, 02 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/169481.php http://www.medicalnewstoday.com/articles/169481.php Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston. Priapism is a condition of persistent painful penile erection in the absence of sexual desire. It is highly associated with sickle cell disease, leukemia and other blood disorders. Erectile Dysfunction / Premature Ejaculation Tue, 20 Oct 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/167971.php http://www.medicalnewstoday.com/articles/167971.php The American College of Physicians (ACP) has issued recommendations for the treatment of erectile dysfunction (ED). ACP, the nation's largest medical specialty organization and second-largest physician group, strongly recommends that physicians initiate therapy with an oral phosphodiesterase type 5 (PDE-5) inhibitor in men who seek treatment for ED unless they have a contraindication to PDE-5 inhibitors, such as nitrate therapy. Erectile Dysfunction / Premature Ejaculation Wed, 14 Oct 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/167212.php http://www.medicalnewstoday.com/articles/167212.php New research indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy, which have increased significantly in recent years, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to a study in the October 14 issue of JAMA, a theme issue on surgical care. Erectile Dysfunction / Premature Ejaculation Wed, 07 Oct 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/166454.php http://www.medicalnewstoday.com/articles/166454.php Las Vegas-based Endogenous Stem Cells Activators Inc. (ESAI) announced that it will award a $1.3 million grant to Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LABioMed) for pre-clinical studies aimed at activating penile endogenous (adult) stem cells with the company's drug, KRONOS IV. Erectile Dysfunction / Premature Ejaculation Mon, 28 Sep 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/165398.php http://www.medicalnewstoday.com/articles/165398.php Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD). These findings appear in the September/October issue of the Journal of Andrology. Heart Disease Sun, 20 Sep 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/164510.php http://www.medicalnewstoday.com/articles/164510.php More than £35,000 of unlicensed erectile dysfunction medicine was seized in Sutton Coldfield yesterday as part of a covert investigation undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA). A 60-year-old man was arrested for possession with intent to supply the medicines which included Kamagra, Savitra and Apcalis, all unlicensed Indian products. Erectile Dysfunction / Premature Ejaculation Sat, 19 Sep 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/164518.php http://www.medicalnewstoday.com/articles/164518.php An innovative drug-delivery system nanoparticles encapsulating nitric oxide or prescription drugs shows promise for topical treatment of erectile dysfunction (ED), according to a new study by scientists at Albert Einstein College of Medicine of Yeshiva University. The new system, tested successfully on a small number of animals, could potentially prevent side effects associated with oral ED medications, if study results can be replicated in humans. Erectile Dysfunction / Premature Ejaculation Thu, 03 Sep 2009 08:00:00 PST http://www.medicalnewstoday.com/articles/162851.php http://www.medicalnewstoday.com/articles/162851.php The Royal Australian College of General Practitioners (RACGP) has voiced concerns about the prescribing practices of erectile dysfunction clinics currently under review by the House of Representatives Standing Committee on Health and Ageing, Roundtable on Impotency Treatments. "Of the greatest concern is the use of telemedicine to treat erectile dysfunction," said Dr Chris Mitchell, RACGP President and GP in Northern NSW . Erectile Dysfunction / Premature Ejaculation Tue, 25 Aug 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/161782.php http://www.medicalnewstoday.com/articles/161782.php Obese men are at increased risk for erectile dysfunction (ED), likely caused by atherosclerosis-related hypertension and cardiovascular disease, as well as hormonal changes associated with obesity, as described in a timely article published in Obesity and Weight Management, a journalzine published by Mary Ann Liebert, Inc. The article is available free online at http://www.liebertpub. Erectile Dysfunction / Premature Ejaculation Thu, 13 Aug 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/160533.php http://www.medicalnewstoday.com/articles/160533.php Palatin Technologies, Inc. (NYSE Amex: PTN) announced the completion of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without blood pressure side effects. Erectile Dysfunction / Premature Ejaculation Mon, 10 Aug 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/160255.php http://www.medicalnewstoday.com/articles/160255.php UroToday.com - A UCLA single-institution study in the online edition of the Journal of Urology reports on the use of erectile aid (EA) following treatment for localized prostate cancer (CaP). Participants with a diagnosis of CaP were prospectively recruited between 1999 and 2003. Clinical and pathological data was abstracted and HRQOL (Health Related Quality of Life) outcomes were prospectively abstracted at baseline and 1, 2, 4, 8, 12, 18, 24, 30, 36, 42 and 48 months. Prostate / Prostate Cancer Mon, 03 Aug 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/159615.php http://www.medicalnewstoday.com/articles/159615.php UroToday.com - Most recently, health-related quality-of-life (HRQOL) after definitive local therapy for prostate cancer has been argued in the patient group with an oncological risk category. Prostate / Prostate Cancer Fri, 31 Jul 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/159381.php http://www.medicalnewstoday.com/articles/159381.php Sciele Pharma Inc., a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE), announced that a second and final Phase III double-blind, placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met all co-primary endpoints of Intra-vaginal Ejaculation Latency Time ('IELT'), Index of Premature Ejaculation ('IPE,' Ejaculatory Control, Sexual Satisfaction and Distress domains). Erectile Dysfunction / Premature Ejaculation Sun, 12 Jul 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/157237.php http://www.medicalnewstoday.com/articles/157237.php UroToday.com - Men with benign prostatic hyperplasia (BPH) often suffer from lower urinary tract symptoms (LUTS; BPH-LUTS) such as urinary frequency, urgency, intermittency, nocturia, straining, incomplete emptying, or weak urinary stream. BPH-LUTS and erectile dysfunction (ED), both highly prevalent conditions in aging men, are frequently associated in the same men, may have common pathophysiological mechanisms, and contribute negatively to quality of life. Erectile Dysfunction / Premature Ejaculation Wed, 01 Jul 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/155875.php http://www.medicalnewstoday.com/articles/155875.php Two Indiana University studies conducted among nationally representative samples of adult American men and women show that vibrator use during sexual interactions is common, with use being reported by approximately 53 percent of women and 45 percent of men ages 18 to 60. Not only is vibrator use common, but the two studies also show that vibrator use is associated with more positive sexual function and being more proactive in caring for one's sexual health. Sexual Health / STDs Wed, 10 Jun 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/153222.php http://www.medicalnewstoday.com/articles/153222.php A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in making treatment decisions. Prostate / Prostate Cancer Sat, 06 Jun 2009 08:00:00 PST http://www.medicalnewstoday.com/articles/152856.php http://www.medicalnewstoday.com/articles/152856.php UroToday.com - Together with Drs. Heruti, Bechor, Justo and Galor, we studied 815 Israeli male adults of whom 305 had complete data and were included in the statistical analysis. In the analyzed population, 2.1% of people without erectile dysfunction (ED) had advanced periodontal disease (defined as recession of periodontal bone of 6 mm or more) in comparison to 9.8% of the mild ED and 15.8% of the moderate/severe ED populations, respectively. Erectile Dysfunction / Premature Ejaculation Sat, 30 May 2009 09:00:00 PST http://www.medicalnewstoday.com/articles/151978.php http://www.medicalnewstoday.com/articles/151978.php UroToday.com - This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil's most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil (Levitra). Erectile Dysfunction / Premature Ejaculation Thu, 28 May 2009 06:00:00 PST http://www.medicalnewstoday.com/articles/151727.php http://www.medicalnewstoday.com/articles/151727.php Premature ejaculation can be embarrassing, but a new study suggests that it might be a genetic disorder. Researchers from Turku, Finland, interviewed more than three thousand men - all pairs of male twins and their older or younger brothers - about the first time they had sex. Many participants in the study reported that they had suffered from erectile dysfunction and premature ejaculation at their first sexual encounter. Erectile Dysfunction / Premature Ejaculation Thu, 14 May 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/149949.php http://www.medicalnewstoday.com/articles/149949.php VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health, announced that it has initiated an open label safety study (TA-314) with its investigational drug, avanafil, in males with erectile dysfunction (ED). Erectile Dysfunction / Premature Ejaculation Thu, 07 May 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/149117.php http://www.medicalnewstoday.com/articles/149117.php Eli Lilly and Company (NYSE: LLY) announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-tolerated, improved erectile function for men with erectile dysfunction (ED) and reported improvement in the sexual quality of life scores for men and their female partners. Erectile Dysfunction / Premature Ejaculation